All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 90 of 206 pages ‹ First < 88 89 90 91 92 > Last ›
HSL8723
Biotech Day In Review: Amgen Hit with SEC Investigation
SeekingAlpha 2007 Mar 1
http://biz.yahoo.com/seekingalpha/070301/28487_id.html?.v=1
HSL8725
Bridges A.
FDA Warns Migraine Medicine Makers
Associated Press 2007 Mar 1
http://biz.yahoo.com/ap/070301/migraine_warnings.html?.v=1
HSL8762
Goodman E.
What Merck needs is vaccine for bad PR
The Boston Globe 2007 Mar 1
http://www.statesman.com/opinion/content/editorial/stories/03/1goodman_edit.html
HSL9001
Jagsi R.
Conflicts of interest and the physician-patient relationship in the era of direct-to-patient advertising.
J Clin Oncol 2007 Mar 1;25:(7):902-5
http://jco.ascopubs.org/cgi/content/full/25/7/902?
HSL9869
Luby M, Howie .
The Best-Sellers List
Pharmaceutical Executive 2007 Mar 1
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=410701&pageID=1&sk=&date=
HSL10201
Konigbauer I.
Advertising and generic market entry.
J Health Econ 2007 Mar 1;26:(2):286-305
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6V8K-4M1CYRB-1&_user=10&_coverDate=03%2F01%2F2007&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=6a2bf992100e2f880578bbd8c71b6c7b
HSL8704
Do Not Use: Black Cohosh Does Not Relieve Symptoms of Menopause
Worst Pills Best Pills Newsletter 2007 Mar
http://www.worstpills.org/member/newsletter.cfm?n_id=521
HSL8764
Center for Drug Evaluation and Research
Guidance: Drug Safety Information – FDA’s Communication to the Public
Rockville, MD: US Food and Drug Administration 2007 Mar
http://web.archive.org/web/20090511234243/http://www.fda.gov/cder/guidance/7477fnl.pdf
HSL8821
Jalnawala N, Wilkin NE.
The effect of DTC advertisement content on belief tenacity: A study of appeals and argument types.
Res Social Adm Pharm 2007 Mar;3:(1):28-46
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17350556&query_hl=1&itool=pubmed_DocSum
HSL9042
Stange KC.
Time to Ban Direct-to-Consumer Prescription Drug Marketing
Ann Fam Med 2007 Mar-Apr;5:(2):101-104
http://www.annfammed.org/cgi/content/full/5/2/101
HSL9066
Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG.
Epidemiology and Reporting Characteristics of Systematic Reviews
PLoS Med 2007 Mar;4:(3):e78
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040078
HSL9067
Kavvoura FK, Liberopoulos G, Ioannidis JPA.
Selection in Reported Epidemiological Risks: An Empirical Assessment
PLoS Med 2007 Mar;4:(3):e79
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040079
HSL9096
Bonn D.
NICE taken to task over unfair decisions.
Lancet Oncol 2007 Mar;8:(3):192
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17348106&query_hl=5&itool=pubmed_DocSum
HSL9100
Newman TB.
Industry-sponsored 'expert committee recommendations for acne management' promote expensive drugs on the basis of weak evidence.
Pediatrics 2007 Mar;119:(3):650
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17332224&dopt=Abstract
HSL9101
Wakeford R.
RE: Secret ties to industry and conflicting interests in cancer research.
Am J Ind Med 2007 Mar;50:(3):239-40
http://www3.interscience.wiley.com/cgi-bin/abstract/114125547/ABSTRACT?CRETRY=1&SRETRY=0
HSL9103
Schultheis LW, Rappaport BA.
The Food and Drug Administration perspective: use of an investigational drug in a medical emergency.
Anesth Analg 2007 Mar;104:(3):479-80
http://www.anesthesia-analgesia.org/cgi/content/full/104/3/479
HSL9169
Morris AW Jr, Gadson SL, Burroughs V.
'For the good of the patient,' survey of the physicians of the National Medical Association regarding perceptions of DTC advertising, Part II, 2006.
J Natl Med Assoc 2007 Mar;99:(3):287-93
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17393955&query_hl=6&itool=pubmed_DocSum
HSL9248
Mueller PS, Hook CC, Litin SC.
Physician preferences and attitudes regarding industry support of CME programs.
Am J Med 2007 Mar;120:(3):281-5
http://linkinghub.elsevier.com/retrieve/pii/S0002-9343(06)01419-7
HSL9249
Kesselheim AS, Mello MM.
Confidentiality laws and secrecy in medical research: improving public access to data on drug safety.
Health Aff (Millwood) 2007 Mar-Apr;26:(2):483-91
http://content.healthaffairs.org/cgi/content/full/26/2/483
HSL9257
Cohen JC, Mrazek M, Hawkins L.
Tackling corruption in the pharmaceutical systems worldwide with courage and conviction.
Clin Pharmacol Ther 2007 Mar;81:(3):445-9
http://www.nature.com/clpt/journal/v81/n3/abs/6100074a.html;jsessionid=15EF59D338258C49D1522EC1F9BDDF89
HSL9272
Etheredge LM.
A rapid-learning health system.
Health Aff (Millwood) 2007 Mar-Apr;26:(2):w107-18
http://content.healthaffairs.org/cgi/content/full/26/2/w107
HSL9274
van Puijenbroek EP, Hepburn PA, Herd TM, van Grootheest AC.
Post Launch Monitoring of food products: what can be learned from pharmacovigilance.
Regul Toxicol Pharmacol 2007 Mar;47:(2):213-20
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WPT-4MR7DDJ-1&_user=10&_coverDate=03%2F31%2F2007&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=cf73d538f80c06117081ac69046af508
HSL9347
Kerwin , Robert .
The House of Commons Health Committee: 'The Influence of the Pharmaceutical Industry' -too much too late?
J Psychopharm 2007 Mar;21:(2):131-133
HSL9362
Mendelson NA.
Regulatory beneficiaries and informal agency policymaking.
Cornell Law Rev 2007 Mar;92:(3):397-452
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Mendelson+NA%22%5BAuthor%5D
HSL9416
Smith J.
The contribution of infant food marketing to the obesogenic environment in Australia.
Breastfeed Rev 2007 Mar;15:(1):23-35
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17424655&dopt=Abstract
HSL9811
Owens J.
Big pharma slims down to bolster productivity.
Nat Rev Drug Discov 2007 Mar;6:(3):173-4
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17396286&query_hl=9&itool=pubmed_DocSum
HSL9854
Light DW.
Globalizing Restricted and Segmented Markets: Challenges to Theory and Values in Economic Sociology
The Annals of the American Academy of Political and Social Science 2007 Mar;610:(1):232=245
http://ann.sagepub.com/cgi/reprint/610/1/232
HSL9977
Lohiya S, Lohiya S.
The Suboptimal Legibility of Prescribing Information in Pharmaceutical Advertisements
The Journal of the American Board of Family Medicine 2007 May-Jun;20:(3):314-315
http://www.jabfm.org/cgi/content/full/20/3/314?etoc
HSL10005
Scott CT, Baker M.
Overhauling clinical trials.
Nat Biotechnol 2007 Mar;25:(3):287-92
http://www.nature.com/nbt/journal/v25/n3/abs/nbt0307-287.html;jsessionid=48991B92B0052686C5352AF84931D5F1
HSL10006
Vastag B.
US aims to tighten rules on direct-to-consumer drug ads.
Nat Biotechnol 2007 Mar;25:(3):267
http://www.nature.com/doifinder/10.1038/nbt0307-267
HSL10007
[No authors listed]
Flogging Gardasil.
Nat Biotechnol. 2007 Mar;25:(3):261
http://www.nature.com/nbt/journal/v25/n3/abs/nbt0307-261.html
HSL10010
Reed RV.
Clarifying conflicts of interest in research.
Arch Dis Child 2007 Mar;92:(3):277
http://adc.bmj.com/cgi/content/full/92/3/277-a
HSL10011
Semin S, Aras S, Guldal D.
Direct-to-consumer advertising of pharmaceuticals: developed countries experiences and Turkey.
Health Expect 2007 Mar;10:(1):4-15
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1369-7625.2006.00411.x
HSL10012
Pace F, Manes G.
Scientific blindness and cognitive dissonance.
Dig Liver Dis 2007 Mar;39:(3):289-90
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B7582-4MY0V07-3&_user=10&_coverDate=03%2F31%2F2007&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=ff9a442f1cd2f71991c0f088f70fa566
HSL10013
Durbin CG Jr.
Is industry guiding the sepsis guidelines? A perspective.
Crit Care Med. 2007 Mar;35:(3):689-91
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?doi=10.1097/01.CCM.0000257723.46818.F3
HSL10052
Blouin C.
Trade policy and health: from conflicting interests to policy coherence.
Bull World Health Organ 2007 Mar;85:(3):169-73
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862007000300008&lng=en&nrm=iso&tlng=en
HSL10060
Mathieu J, Ahearne M, Taylor SR.
A longitudinal cross-level model of leader and salesperson influences on sales force technology use and performance.
J Appl Psychol 2007 Mar;92:(2):528-37
http://content2.apa.org/journals/apl/92/2/528
HSL10076
Holm RP; South Dakota Medical Association Committee on Ethics and Judicial Affairs.
A quiz on "the ethics of accepting gifts from industry".
S D Med 2007 Mar;60:(3):117-8
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17455581&query_hl=9&itool=pubmed_DocSum
HSL10079
Adams L, Geuens M.
Healthy or unhealthy slogans: that's the question...
J Health Commun. 2007 Mar;12:(2):173-85
http://www.informaworld.com/smpp/content?content=10.1080/10810730601152755
HSL10080
Nathan C.
Aligning pharmaceutical innovation with medical need.
Nat Med 2007 Mar;13:(3):304-8
http://www.nature.com/nm/journal/v13/n3/abs/nm0307-304.html;jsessionid=34363E3CB4150001B80AA307BDD40922
HSL10081
Keim B.
Canceled conference puts conflicts of interest under scrutiny.
Nat Med 2007 Mar;13:(3):230
http://www.nature.com/doifinder/10.1038/nm0307-230a
HSL10083
Knight LV, Sweeney K.
Revealing implicit understanding through enthymemes: a rhetorical method for the analysis of talk.
Med Educ 2007 Mar;41:(3):226-33
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2929.2006.02681.x
HSL10084
Tormala ZL, Desensi VL, Petty RE.
Resisting persuasion by illegitimate means: a metacognitive perspective on minority influence.
Pers Soc Psychol Bull 2007 Mar;33:(3):354-67
http://psp.sagepub.com/cgi/reprint/33/3/354
HSL10132
Lonsdale J.
Policy and politics.
J R Soc Health 2007 Mar;127:(2):54
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17402305&query_hl=5&itool=pubmed_DocSum
HSL10139
Craddock S.
Market incentives, human lives, and AIDS vaccines.
Soc Sci Med 2007 Mar;64:(5):1042-56
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-4MC71SP-1&_user=10&_coverDate=03%2F31%2F2007&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=d1dc2c065d454dc4d4a9ebc24cb5d4a1
HSL10197
Kellerman R; American Academy of Family Physicians.
AAFP supports improvement, not ban, on direct-to-consumer prescription drug ads.
Ann Fam Med 2007 Mar-Apr;5:(2):180-1
http://www.annfammed.org/cgi/content/full/5/2/180
HSL10334
Parent SJ, Ward A, Mann T.
Health information processed under limited attention: is it better to be 'hot' or 'cool?'
Health Psychol 2007 Mar;26:(2):159-64
http://content2.apa.org/journals/hea/26/2/159
HSL10573
Kelly L, Lazzaro M, Petersen C.
Canadian drug regulatory framework.
Can J Neurol Sci 2007 Mar;34:
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17469674&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL10574
Cassell GH.
Interactions of the public and private sectors in drug development: boundaries to protect scientific values while preserving innovation.
Cleve Clin J Med 2007 Mar;74:
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17469473&dopt=Abstract
HSL10575
Vagelos PR.
Innovation and industry-academia interactions: where conflicts arise and measures to avoid them.
Cleve Clin J Med 2007 Mar;74:
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17469468&dopt=Abstract
HSL10578
Patnaik MM, Stauffer WM, Campagna A, Stauffer CI, Walker PF.
When the market fails, the poor pay.
Minn Med 2007 Mar;90:(3):38-40
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17432756&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL10682
[No authors listed].
Docs in ads: friends or faux?
Consum Rep 2007 Mar;72:(3):7
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17523258&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL10698
Bouvier M.
[Will academic research rescue the drug discovery crisis?]
Med Sci (Paris) 2007 Mar;23:(3):227-8
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17349271&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL10776
Wertheimer AI, Santella TM.
Innovation and the WHO's essential medicines list: giving credit where credit is due.
Res Social Adm Pharm 2007 Mar;3:(1):137-44
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17350562&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL10784
Rogers , W.a.
The tangled web of medical and commercial interests
Health Expectations 2007 Mar;10:(1):1-3
HSL10954
Pochet A.
[Current status of cosmetic product regulation].
Ann Dermatol Venereol 2007 Mar;134:(3):
http://www.masson.fr/masson/portal/bookmark?Global=1&Page=18&MenuIdSelected=106&MenuItemSelected=0&MenuSupportSelected=0&CodeProduct4=170&CodeRevue4=AD&Path=REVUE/AD/2007/134/3C2/ARTICLE11815782179.xml&Locations=
HSL11139
Fagundes MJ, Soares MG, Diniz NM, Pires JR, Garrafa V.
[Bioethical analysis of drugs advertisement and publicity].
Cien Saude Colet 2007 Mar;12:(1):221-229
http://www.scielosp.org/scielo.php?script=sci_abstract&pid=S1413-81232007000100025&lng=&nrm=iso
HSL11229
Bernardi D, Errante D, Bianco A, Salvagno L.
Are sales representatives and the sale strategies of pharmaceutical companies getting too aggressive towards physicians?
Ann Oncol 2007 Mar;18:(3):607
http://annonc.oxfordjournals.org/cgi/content/full/18/3/607
HSL11591
Campbell D, Walker R, Mathew T, Craig J.
Commentary on 'Influence of industry on renal guideline development'.
Clin J Am Soc Nephrol 2007 Mar;2:(2):211
HSL11592
Nissenson AR.
Influence of industry on renal guideline development commentary: keeping our eye on the ball and improving chronic kidney disease patient outcomes.
Clin J Am Soc Nephrol 2007 Mar;2:(2):205-6
http://cjasn.asnjournals.org/cgi/content/full/2/2/205
HSL11594
Mascarenhas D, Singh BK, Singh AH, Veer SV.
Early adoption of new drug treatments: the role of continuing medical education and physician adaptivity.
Crit Pathw Cardiol 2007 Mar;6:(1):30-40
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?doi=10.1097/01.hpc.0000257844.53130.d0
HSL11611
Kassirer JP.
Stacking the deck.
Clin J Am Soc Nephrol 2007 Mar;2:(2):212
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17699414
HSL11675
Leibowitz AA, Sood N.
Market power and state costs of HIV/AIDS drugs.
Int J Health Care Finance Econ 2007 Mar;7:(1):59-71
http://www.springerlink.com/content/8j873267p334v6v1/
HSL11714
Nordlund C.
Hormones for life? Behind the rise and fall of a hormone remedy (Gonadex) against sterility in the Swedish welfare state
Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 2007 March;
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VHP-4N1SK1B-9&_user=10&_coverDate=03%2F31%2F2007&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=66ff12289e4288675a601a29fec617d4
HSL11980
Spurling G, Kyle G.
Is your sample cupboard relevant to your practice?
Aust Fam Physician 2007 Mar;36:(3):187-8,
http://www.racgp.org.au/Content/NavigationMenu/Publications/AustralianFamilyPhys/2007issues/afp200703/200703spurling.pdf
HSL12246
Weigand TJ.
Captive subjects: pharmaceutical testing and prisoners.
J Med Toxicol 2007 Mar;3:(1):37-9
http://www.ncbi.nlm.nih.gov/pubmed/18072157
HSL12930
Dainesi SM.
[There are advantages in seeking universal model contract for clinical studies sponsored by industry?]
Rev Assoc Med Bras 2007 Mar-Apr;53:(2):100
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302007000200007&lng=en&nrm=iso&tlng=en
HSL13032
Greving JP, Denig P, de Zeeuw D, Haaijer-Ruskamp FM.
Abstract
Claims in advertisements for antihypertensive drugs in a Dutch medical journal.
J Hypertens 2007 Mar;25:(3):713-22
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00004872-200703000-00030
HSL13365
Cassels A.
Prevention vs. drugs. The real Conversation on Health
Common Ground 2007 Mar
http://commonground.ca/iss/0702188/cg188_prevention.shtml
HSL14368
de Beaufort I, Vandamme S.
'No willpower required'. The slimming industry and the right to sell dreams
Med Law 2008 Mar;27:(1):215-28.
http://www.ncbi.nlm.nih.gov/pubmed/18592893
HSL8913
Larsson J.
Creating a market – long lines and ADHD drugs
Privately published blog 2007 Feb 28
http://jannel.se/kadesjo-lilly.pdf
HSL9170
Svensson S, Mellen A.
[What can we learn from the marketing of TrioBe?]
Lakartidningen 2007 Feb 28-Mar;
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17393869&query_hl=8&itool=pubmed_docsum
HSL8637
Putin says foreign drugmakers earn too much on Russian program
Budapest Business Journal 2007 Feb 27
http://www.bbj.hu/main/news_23308_putin+says+foreign+drugmakers+earn+too+much+on+russian+program.html
HSL8638
AstraZeneca, GlaxoSmithKline, Merck & Novartis Vie for Multiple Honors - DTC Perspectives Announces Advertising Awards Finalists for the DTC Pharmaceutical Marketing Industry
PharmaLive,com 2007 Feb 27
http://www.medadnews.com/News/Index.cfm?articleid=419079
HSL8641
Vitamins A and E shorten, not lengthen life, review suggests
CBC News 2007 Feb 27
http://www.cbc.ca/health/story/2007/02/27/antioxidants-risks.html#skip300x250
HSL8642
Lee J.
Regulator halts ads for weight loss drug
The Sydney Morning Herald 2007 Feb 27
http://www.smh.com.au/news/business/regulator-halts-ads-for-weight-loss-drug/2007/02/26/1172338548085.html
HSL8643
FDA Commissioner To Testify Before House Panel TOMORROW (February 28 2007)
Alliance for Human Research Protection 2007 Feb 27
http://ahrp.blogspot.com/2007/02/fda-commissioner-to-testify-before.html
HSL8644
Brody JE.
A Mix of Medicines That Can Be Lethal
New York Times 2007 Feb 27
http://www.nytimes.com/2007/02/27/health/27brody.html?_r=1&ref=health&oref=slogin
HSL8645
Support for quality pharmacy services
The Hon Tony Abbott MHR - Minister for Health and Ageing 2007 Feb 27
http://www.health.gov.au/internet/ministers/publishing.nsf/Content/mr-yr07-ta-abb016.htm?OpenDocument&yr=2007&mth=2
HSL8737
Mansfield PR, Hoffman JR, Lexchin J.
Educating Health Professionals about Drug and Device Promotion: Authors' Reply.
PLoS Med. 2007 Feb 27;4:(2):e88
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040088
HSL8639
Henderson D.
Counter-detailers help doctors wade through drug company marketing
The Boston Globe 2007 Feb 26
http://www.medicalprogresstoday.com/news/news_indarchive.php?id=1591
HSL8640
Gardner A.
Industry-Funded Breast Cancer Trials Show More Positive Results
HealthDay News 2007 Feb 26
http://www.healthday.com/Article.asp?AID=602184
HSL8648
Edwards J.
Pfizer Taking Some Hits Over 'Billion-Dollar Bong'
Brandweek 2007 Feb 26
http://www.brandweek.com/bw/magazine/current/article_display.jsp?vnu_content_id=1003550010
HSL8649
Dunham W.
Industry-backed drug studies yield rosier findings
Reuters 2007 Feb 26
http://www.reuters.com/article/healthNews/idUSCOL66551120070226?pageNumber=1
HSL8651
Pringle E.
Activists Take on Eli Lilly Over Off-Label Sale of Zyprexa
Best Syndication 2007 Feb 26
http://www.bestsyndication.com/?q=022607_protestors-rally-with-battle-with-zyprexa-pharmaceutical-companies.htm
HSL8653
Angell M.
Taking back the FDA
The Boston Globe 2007 Feb 26
http://www.boston.com/news/globe/editorial_opinion/oped/articles/2007/02/26/taking_back_the_fda/
HSL8756
Cresswell A.
Weight-loss pill maker slams ad ban
The Australian 2007 Feb 26
http://www.theaustralian.news.com.au/story/0,20867,21288826-23289,00.html
HSL8757
Fisher J.
Industry role in research analyzed
The News & Observer (Raleigh, North Carolina) 2007 Feb 26
http://web.archive.org/web/20081202140138/http://www.newsobserver.com/674/story/547417.html
HSL8758
Peppercorn J, Blood E, Winer E, Partridge A.
Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.
Cancer 2007 Feb 26;
http://www3.interscience.wiley.com/cgi-bin/accessdenied?ID=114129807&Act=2138&Code=4719&Page=/cgi-bin/fulltext/114129807/HTMLSTART
HSL8760
Underwood A.
Too Good to Be True?
Newsweek 2007 Feb 26
http://www.msnbc.msn.com/id/17344198/site/newsweek/
HSL8927
Remsen N.
Senate takes aim again at drug companies
Burlington Free Press 2007 Feb 26
http://www.burlingtonfreepress.com/apps/pbcs.dll/article?AID=/20070226/NEWS02/702260302&theme=
HSL8935
Verispan Reports: Majority of Physicians Surveyed Say ePromotion Is as Reliable as Face-to-Face Promotion
Verispan 2007 Feb 26
http://www.verispan.com/about/press_release_details.php?id=99rj84987z
HSL9125
Us Weekly, Eat Your Heart Out: These Celebrities Are All On Drugs
Brandweek 2007 Feb 26
http://www.brandweek.com/bw/search/article_display.jsp?vnu_content_id=1003549981
HSL8654
Goodyer P.
Weight for it
The Age (Melbourne) 2007 Feb 25
http://www.theage.com.au/news/epicure/weight-for-it/2007/02/22/1171733945890.html
HSL8656
Egan C.
Fears as patients flock to buy drugs on internet
The Age (Melbourne) 2007 Feb 25
http://www.theage.com.au/news/national/fears-as-patients-flock-to-buy-drugs-on-internet/2007/02/24/1171734074127.html
HSL8657
McColl G.
Healthcare's sticking point
The Age (Melbourne) 2007 Feb 25
http://www.theage.com.au/news/national/healthcares-sticking-point/2007/02/24/1171734074136.html
HSL8753
Henderson D.
How safe is Celebrex?
The Boston Globe 2007 Feb 25
http://www.boston.com/business/globe/articles/2007/02/25/how_safe_is_celebrex/?page=1
HSL8754
May J.
The race is on to develop a magic bullet for bedroom problems like premature ejaculation and, for women, low sexual arousal
Star-Ledger (New Jersey) 2007 Feb 25
http://www.nj.com/starledger/stories/index.ssf?/base/business-5/1172381961166670.xml&coll=1&thispage=1
HSL9338
Most tsunami drug donations were useless and dangerous
The Sunday Times Online (Colombo, Sri Lanka) 2007 Feb 25
http://sundaytimes.lk/070225/News/106news.html
HSL8658
Coombes R.
Having the last laugh at big pharma
BMJ 2007 Feb 24;334:(7590):396
http://www.bmj.com/cgi/content/full/334/7590/396
Page 90 of 206 pages ‹ First < 88 89 90 91 92 > Last ›
